Analgesics Market GNW_11zon.jpg
Analgesics Market to Reach USD 56.86 Million by 2030, States a New Report by Next Move Strategy Consulting
February 09, 2023 09:00 ET | Next Move Strategy Consulting
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the Global Analgesics Market is estimated to be USD 35.03 million in 2021 and is...
Global Advanced Drug Delivery Market Anticipated to Generate a Revenue of $94,352.5 Million and Rise at a CAGR of 10.0% during the Analysis Timeframe from 2021 to 2028 [175-Pages] | Announced by Research Dive
February 06, 2023 09:00 ET | Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global advanced drug delivery market is projected to generate a revenue of $94,352.5 million...
US Transdermal Patch Drug Delivery Market Size Clinical Trials Forecast 2026
November 18, 2021 08:14 ET | KuicK Research
Delhi, Nov. 18, 2021 (GLOBE NEWSWIRE) -- US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026 Report Highlights: US Transdermal Patch Market InsightUS Transdermal Patch...
IGX Bigger Size Logo.jpg
IntelGenx to Join the Quebec Pavilion at BIO 2019 International Convention
May 23, 2019 08:00 ET | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it will be joining the Quebec...
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome
July 09, 2018 06:55 ET | Zynerba Pharmaceuticals, Inc.
Study will Evaluate the Efficacy and Safety of Transdermally-Delivered Cannabidiol (CBD) in Children and Adolescents with Fragile X Syndrome Top Line Results Expected in Second Half of 2019 Zynerba...
NanoSphere Health Sciences: Advancing the Industry with Breakthrough Cannabinoid Delivery -- CFN Media
May 10, 2018 08:45 ET | CFN Media
SEATTLE, May 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an...
NanoSphere Health Sciences Achieves Landmark Patent -- CFN Media
April 10, 2018 08:30 ET | CFN Media; NanoSphere Health Sciences Inc.
SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of...
Agile_Logo-color on white.jpg
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
March 14, 2018 07:45 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...
Zynerba Pharmaceuticals Provides 2018 Clinical and Corporate Update
January 03, 2018 16:30 ET | Zynerba Pharmaceuticals, Inc.
 - Focusing Strategy on Rare and Near-Rare Neurological and Psychiatric Disorders - - Pediatric Neurologist Liza Squires, M.D. Joins as Chief Medical Officer - - Conference Call to be Held at 8:30...
Agile_Logo-color on white.jpg
Agile Therapeutics Inc. Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy
October 10, 2017 18:38 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today hosted the Company’s first analyst day in New York City to showcase its...